Saerom Ham is a business development professional currently serving as an APAC BD manager at Lunit Global. They have conducted data analysis and developed business strategies for biosimilar products in Southeast Asia, collaborating with medical affairs teams to create materials for healthcare providers. Saerom previously held roles such as Country Manager at Celltrion Healthcare, where they successfully managed product launches and maintained a 97% market share in Sri Lanka's Infliximab market. They obtained a Bachelor's degree in Chinese from 한국외국어대학교 in 2014.
This person is not in any offices